The Vaccine Vector Design Team designs, generates, and characterizes innovative viral vaccines that target emerging infectious diseases. Our primary focus is on creating recombinant vesicular stomatitis virus (VSV)-based vaccine vectors. Additionally, we develop analytical assays to assess viral vectors and vaccine materials. The team is also responsible for producing materials compliant with current good manufacturing practice (cGMP) regulations and will provide support for preclinical studies and clinical product development.
Ying Wang, Ph. D.,
Principal Scientist, Vector Design
Ying Wang joined the DDL in 2024 and is the principal scientist for the Vectors design team. She has over 8 years of experience in preclinical development of live attenuated vaccines, including work on vaccines for Dengue, Zika, and SARS-CoV-2.
Meet the Vaccine Vector Design Team
Kezhi Dai, Ph.D., Analytical Scientist II
Fuxiang Hou, Analytical Scientist I
Shui Li, Research Associate II
Lucia Reiserova, Analytical Scientist I
